1. High-throughput screening assay identifies drugs that modulate the release of vasculo-inflammatory extracellular vesicles enriched in mitochondrial content. (August 2022) Authors: Zisser, L.; Afonyushkin, T.; Puhm, F.; Ringler, A.; Kubicek, S.; Hacker, M.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Natural igm recognizing oxidation-specific epitopes block netosis induced by extracellular vesicles. (August 2022) Authors: Ondracek, A.S.; Afonyushkin, T.; Taqi, S.; Hofbauer, T.M.; Kozma, M. Ozsvar; Sharma, S.; Scherz, T.; Beitzke, D.; Testori, C.; Lang, I.M.; Binder, C.J. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oxidized low‐density lipoprotein in inflammation‐driven thrombosis. (24th January 2018) Authors: Obermayer, G.; Afonyushkin, T.; Binder, C. J. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 3(2018) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The generation of malondialdehyde-positive microvesicles. (September 2016) Authors: Puhm, F.; Afonyushkin, T.; Binder, C. Journal: Atherosclerosis Issue: Volume 252(2016) Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗